login
login
Image header Agence Europe
Europe Daily Bulletin No. 12819
Contents Publication in full By article 21 / 30
EU RESPONSE TO COVID-19 / Health

European Medicines Agency to start review of a ninth candidate treatment for Covid-19

The European Medicines Agency (EMA) announced on Monday 25 October that it had begun the rolling review of a new candidate treatment for Covid-19: molnupiravir (MK-4482 or Lagevrio), an oral antiviral developed by the American pharmaceutical companies Merck Sharp & Dohme and Ridgeback Biotherapeutics.

Preliminary results from laboratory studies indicate that the drug “may reduce the ability of SARS-CoV-2 to multiply in the body, thereby preventing hospitalisation or death in patients with...

Contents

SECTORAL POLICIES
ECONOMY - FINANCE - BUSINESS
EXTERNAL ACTION
YOUTH
EU RESPONSE TO COVID-19
INSTITUTIONAL
NEWS BRIEFS